# NEVRO CORP

NEVRO CORP is a company headquartered in Redwood City, CA, United States.

## Company overview

- **Legal name:** NEVRO CORP
- **Classification:** Company
- **Industry (SIC):** 3841 — Surgical & Medical Instruments & Apparatus
- **Headquarters:** Redwood City, CA, United States
- **Fiscal year end:** December 31
- **SEC CIK:** 0001444380

## About

NEVRO CORP is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001444380, and its reported industry is Surgical & Medical Instruments & Apparatus. In 10-K filed on 2025-03-04, it reported annual revenue of USD 408,518,000; net income of USD -113,439,000; total assets of USD 553,841,000 for the fiscal period ended 2024-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2024 (period ended 2024-12-31)

- **Revenue:** $408.5M (USD 408,518,000)
- **Net income:** -$113.4M (USD -113,439,000)
- **Total assets:** $553.8M (USD 553,841,000)
- **Cash and equivalents:** $94.5M (USD 94,539,000)
- **Operating cash flow:** -$19.4M (USD -19,439,000)

### FY2023 (period ended 2023-12-31)

- **Revenue:** $425.2M (USD 425,174,000)
- **Net income:** -$92.2M (USD -92,213,000)
- **Total assets:** $635.7M (USD 635,713,000)
- **Cash and equivalents:** $104.2M (USD 104,217,000)
- **Operating cash flow:** -$58.8M (USD -58,829,000)

### FY2022 (period ended 2022-12-31)

- **Revenue:** $406.4M (USD 406,365,000)
- **Net income:** $3.0M (USD 3,001,000)
- **Total assets:** $602.4M (USD 602,408,000)
- **Cash and equivalents:** $120.4M (USD 120,373,000)
- **Operating cash flow:** $24.7M (USD 24,675,000)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $386.9M (USD 386,905,000)
- **Net income:** -$131.4M (USD -131,360,000)
- **Total assets:** $574.5M (USD 574,544,000)
- **Cash and equivalents:** $34.7M (USD 34,710,000)
- **Operating cash flow:** -$41.9M (USD -41,881,000)

## Recent SEC filings

- Form 8-K — filed 2025-04-03 — period 2025-04-01 — 8-K
- Form 8-K — filed 2025-04-02 — period 2025-04-02 — 8-K
- Form 10-K — filed 2025-03-04 — period 2024-12-31 — 10-K
- Form 8-K — filed 2025-03-04 — period 2025-03-04 — 8-K
- Form 8-K — filed 2025-02-06 — period 2025-02-06 — 8-K
- Form 8-K — filed 2025-01-14 — period 2025-01-13 — 8-K
- Form SC 13G — filed 2024-12-04
- Form 8-K — filed 2024-11-14 — period 2024-11-11 — 8-K
- Form 10-Q — filed 2024-11-12 — period 2024-09-30 — 10-Q
- Form 8-K — filed 2024-08-06 — period 2024-06-30 — 8-K
- Form 10-Q — filed 2024-08-06 — period 2024-06-30 — 10-Q
- Form 8-K — filed 2024-05-29 — period 2024-05-23 — 8-K

---

Updated: 2026-10-23T19:32:55Z

Canonical page: https://altss.com/profile/nevro-corp

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology